HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,227,030 | -10.0% | 434,148 | -3.3% | 2.09% | -5.2% |
| Q2 2023 | $15,801,647 | +8.7% | 449,038 | +0.8% | 2.21% | +1.4% |
| Q1 2023 | $14,542,898 | -26.0% | 445,418 | +24.9% | 2.18% | -28.6% |
| Q4 2022 | $19,650,754 | -9.6% | 356,638 | -27.3% | 3.05% | -8.1% |
| Q3 2022 | $21,736,000 | -33.2% | 490,768 | -26.4% | 3.32% | -28.3% |
| Q2 2022 | $32,542,000 | +1.4% | 667,248 | +1.1% | 4.62% | +33.7% |
| Q1 2022 | $32,103,000 | +8.4% | 659,873 | -5.0% | 3.46% | +17.1% |
| Q4 2021 | $29,626,000 | +22.6% | 694,783 | +10.2% | 2.95% | +34.5% |
| Q3 2021 | $24,166,000 | +34.2% | 630,473 | -1.2% | 2.20% | +35.1% |
| Q2 2021 | $18,012,000 | -15.7% | 638,033 | -1.3% | 1.62% | -18.6% |
| Q1 2021 | $21,366,000 | +116.5% | 646,673 | +136.9% | 2.00% | +109.0% |
| Q4 2020 | $9,867,000 | – | 272,950 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |